Data / Drug companies / Gobrands, Inc
Gobrands, Inc: 14 products in the FDA NDC directory, labeler code 82501
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Gobrands, Inc (labeler code 82501) lists 14 products in the FDA National Drug Code Directory, covering 10 finished drugs by generic name. By type: 14 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on September 1, 2026.
The request: Watch Gobrands, Inc (FDA labeler code 82501): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 82501
- Products in commercial distribution
- 14
- Packages
- 14
- Finished drugs by generic name
- 10
- Prescription products
- 0
- Over the counter products
- 14
- Flagged as original packager
- 13 of 13 products that carry the flag
- Started marketing in the last 12 months
- 1
- Earliest marketing start
- April 15, 2022
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 7 | 50% |
| Generic drugs (ANDA) | 6 | 42.9% |
| New drug applications (NDA) | 1 | 7.1% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 14 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Loratadine | 2 | 125 |
| Ibuprofen | 2 | 190 |
| Naproxen sodium | 1 | 100 |
| Isopropyl alcohol | 1 | 177 |
| Acetaminophen | 1 | 214 |
| Omeprazole | 1 | 106 |
| Bismuth subsalicylate | 1 | 80 |
| Diphenhydramine hcl | 1 | 99 |
| Hydrogen peroxide | 1 | 100 |
| Cetirizine hydrochloride | 1 | 119 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 3 | 21.4% |
| Tablet, film coated | 3 | 21.4% |
| Liquid | 3 | 21.4% |
| Kit | 2 | 14.3% |
| Tablet, delayed release | 1 | 7.1% |
| Solution | 1 | 7.1% |
| Capsule, liquid filled | 1 | 7.1% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
| Class | Products |
|---|---|
| Nonsteroidal Anti-inflammatory Drug | 3 |
| Histamine-1 Receptor Antagonist | 2 |
| Proton Pump Inhibitor | 1 |
| Bismuth | 1 |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Ibuprofen | 82501-1010 | Capsule, liquid filled | Generic drugs (ANDA) | September 1, 2026 |
| Goodnow Cold and Flu Day Relief Cold and Flu Night Relief | 82501-0733 | Kit | Over the counter monograph drugs | October 29, 2025 |
| Goodnow allergy relief | 82501-0612 | Tablet | Generic drugs (ANDA) | October 27, 2025 |
| Goodnow allergy relief | 82501-0422 | Tablet, film coated | Generic drugs (ANDA) | October 27, 2025 |
| Goodnow cold flu day relief cold flu night relief | 82501-1211 | Kit | Over the counter monograph drugs | October 23, 2025 |
| Goodnow pain relief | 82501-0604 | Tablet, film coated | Generic drugs (ANDA) | October 23, 2025 |
| Goodnow pain relief | 82501-0484 | Tablet | Over the counter monograph drugs | October 23, 2025 |
| Goodnow sleep aid | 82501-0186 | Solution | Over the counter monograph drugs | October 23, 2025 |
| Hydrogen Peroxide | 82501-0871 | Liquid | Over the counter monograph drugs | January 24, 2024 |
| Isopropyl Alcohol | 82501-0810 | Liquid | Over the counter monograph drugs | January 24, 2024 |
| Good now omeprazole | 82501-0915 | Tablet, delayed release | New drug applications (NDA) | July 21, 2023 |
| Pain Relief | 82501-1576 | Tablet, film coated | Generic drugs (ANDA) | May 30, 2022 |
| Loratadine | 82501-1580 | Tablet | Generic drugs (ANDA) | May 16, 2022 |
| Stomach Relief Regular Strength | 82501-7240 | Liquid | Over the counter monograph drugs | April 15, 2022 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.